Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Dawei GuoChen Liu

Abstract

Brain-derived neurotrophic factor (BDNF) and its primary receptor tropomysin-related kinase B (TrkB) mediate critical signalings for supporting survival and growth of neurons. Even though we have previously confirmed that more expressions of BDNF and TrkB were closely correlated with multiple and advanced hepatocellular carcinoma (HCC), the exact mechanisms underlying have not been investigated. The expressions of BDNF and TrkB were examined by western blot and BDNF secretion was evaluated by ELISA in human HCC cell lines of HepG2 and HCCLM3 with high metastatic potential. BDNF knockdown was performed by specific BDNF-siRNA transfection in HCC cells, actin cytoskeleton was shown by FITC-phalloidin staining and the activations of RhoA, Rac1 or Cdc42 were determined using western blot. Cell apoptosis and invasion were examined by flow cytometry and transwell assay, respectively. More expressions of BDNF and TrkB were found in HCCLM3 than in HepG2 cells. Inhibited expression of BDNF by specific siRNA showed impaired actin polymerization and decreased activations of RhoA or Rac1 in both HepG2 and HCCLM3 cells. BDNF knockdown also induced apoptosis and suppressed invasion of both HepG2 and HCCLM3 cells. Our results suggested a role ...Continue Reading

References

Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A EggertA E Evans
May 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Junji YamauchiEric M Shooter
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yuki MiyamotoWilliam C Mobley
Oct 13, 2006·Molecular Biology and Evolution·Anthony BoureuxPhilippe Fort
Mar 8, 2007·PLoS Biology·Zelda H CheungNancy Y Ip
Jul 10, 2007·Cancer Research·Thomas R Geiger, Daniel S Peeper
Nov 15, 2007·Clinical & Experimental Metastasis·Saskia I J Ellenbroek, John G Collard
May 7, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Garrett M BrodeurAudrey E Evans
Feb 6, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Yingjiao YuGuocheng Ou
Sep 30, 2010·Oncology Reports·Pei Chun LaiYen Ta Huang
Nov 16, 2010·Cellular and Molecular Neurobiology·Baodong ChenXiaodan Jiang
Feb 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elsa VanheckeHubert Hondermarck
Mar 23, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi-Tat LamRonnie T P Poon

❮ Previous
Next ❯

Citations

Mar 28, 2013·World Journal of Surgical Oncology·Li XiongXiongying Miao
Oct 15, 2019·Anti-cancer Drugs·Lijie MaXudong Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis